Researchers use AI, implants to help ALS patient speak again - CBS News
WEB2 days ago · Using artificial intelligence, doctors have found a way to give people who lost their voice to ALS the ability to speak again.
Updates on ACT for ALS - National Institute of Neurological …
WEB23 hours ago · Updates on ACT for ALS. Thursday, September 19, 2024. Amyotrophic Lateral Sclerosis, or ALS, is a progressive and fatal neurodegenerative disease, affecting around 30,000 people in the United States. Although some cases of ALS are inherited, the majority are sporadic, meaning that they occur with no known family history.
ALS News Today Home | ALS News Today
WEB2 days ago · Targeting 3 cell types at same time seen to extend survival in ALS mice. A strategy that simultaneously targets motor neurons, astrocytes, and microglia — three cell types involved in the development and progression of amyotrophic lateral sclerosis (ALS) — was shown to further extend survival in a mouse model of the disease.
A “Game-Changer” – Groundbreaking Discovery Paves Way for ALS …
WEBMay 29, 2024 · In a groundbreaking Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral sclerosis (ALS).
New Treatment Strategy Offers Hope for Halting ALS Progression
WEBJan 30, 2024 · A major breakthrough in the treatment of amyotrophic lateral sclerosis, known as ALS, can potentially help stop the disease in its tracks in as much as half of …
Amyotrophic Lateral Sclerosis News -- ScienceDaily
WEBMar 13, 2024 · Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments.
Scientists may have discovered a potential cure for ALS - The Toronto Star
WEBMay 17, 2024 · A team of researchers at Western University have made a major breakthrough that could pave the way to a cure for amyotrophic lateral sclerosis (ALS) — a devastating nervous system disease that...
FDA Approves First ALS Treatment Via Accelerated Approval
WEBApr 25, 2023 · ALS Association Funded Antisense Technology Behind Tofersen. Washington, D.C. (April 25. 2023) – The ALS Association commends the FDA for approving tofersen under the agency’s accelerated approval pathway for the treatment of people living with ALS connected to mutations in the SOD1 gene.
Report Urges Immediate and Longer-Term Actions to Improve …
WEBJun 18, 2024 · WASHINGTON — A new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine recommends actions Congress, federal agencies, insurers, and others should take to strengthen health care and support services for people with amyotrophic lateral sclerosis (ALS) …
In reversal, FDA panel votes to recommend experimental ALS drug - NBC News
WEBSep 7, 2022 · A Food and Drug Administration advisory panel voted Wednesday to recommend an experimental drug for patients with ALS, a reversal from its decision in March and a victory for advocacy groups ...